News
Hosted on MSN21d
From Phase I to Phase II: Clone Armor Explained - MSNExplore the evolution of Clone Trooper armor from Phase I to Phase II, highlighting key design changes and tactical upgrades. This video breaks down the differences in helmet structure, armor ...
Hosted on MSN20d
Star Wars: Clone Trooper Captains Uncovered - MSNThis video offers an in-depth exploration of the Clone Trooper Captains from the Star Wars universe, highlighting their unique roles, personalities, and contributions during the Clone Wars. From ...
5) Phase 1 Clone Trooper Helmet Multiple variations of clone trooper helmet exist in Star Wars, but Phase 1’s style is the coolest.
Quiver AI Summary Passage Bio, Inc. announced positive results from the ongoing Phase 1/2 upliFT-D clinical trial assessing PBFT02 for treating frontotemporal dementia (FTD) with granulin mutations.
KL264-01/MK-2870-001 is a Phase 1/2 first-in-human trial of sac-TMT as monotherapy in patients who have an unresectable locally advanced or metastatic solid tumor which is refractory to standard ...
(RTTNews) - Sangamo Therapeutics, Inc. (SGMO) Tuesday reported positive topline results from the registrational Phase 1/2 STAAR study of its gene therapy candidte isaralgagene civaparvovec for the ...
CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from the Phase 1/2 study (KL264-01/MK-2870-001 ...
SAN DIEGO and TORONTO, June 12, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, today announced data ...
As of a February 28, 2025, data cut-off, a total of 17 patients with severe SCD were treated with BEAM-101 and included in the safety and efficacy analysis, with follow-up ranging from 0.2 to 15.1 ...
32nd Annual FSHD Society International Research Congress Presentations Topline Data from Dose Escalation Cohorts A and B in FORTITUDE™, a Phase 1/2 Trial Evaluating Del-brax (delpacibart ...
There were 49 patients who received the recommended Phase 2 dose of 100 x 10 6 CAR T cells; two patients received a dose of 300 x 10 6 CAR T cells. CD19/CD20 screening was not required prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results